Announcements Trials

Browse Landscape

Phase

Status

Completed 15 Terminated 6 Recruiting 5 Unknown 3 Not yet recruiting 3 Suspended 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 35 Breast Neoplasms 30 Prostatic Neoplasms 22 Leukemia, Myeloid, Acute 20 Colorectal Neoplasms 20 Melanoma 17 Pancreatic Neoplasms 16 Glioblastoma 16 Carcinoma, Non-Small-Cell Lung 16 Neoplasm Metastasis 15 Lung Neoplasms 13 Brain Neoplasms 13 Glioma 12 Stomach Neoplasms 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Myelodysplastic Syndromes 11 Carcinoma, Hepatocellular 11 Ovarian Neoplasms 10 Multiple Myeloma 9 Head and Neck Neoplasms 9 Triple Negative Breast Neoplasms 8 Lymphoma 8 Carcinoma, Renal Cell 8 Leukemia 7 Sarcoma 6 Rectal Neoplasms 6 Hematologic Neoplasms 6 Esophageal Neoplasms 6 Uterine Cervical Neoplasms 5 Recurrence 5

Interventions

Prednisone 1 Clinical Protocols 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Interventional × Pneumonia × Clear all

NCT04036721 2023-02-23

PROS-CONS

National Institute for Tuberculosis and Lung Diseases, Poland

Phase 4 Suspended

Lung Neoplasms, Pneumonia, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡